NewsBenzinga노바백스, 2026회계연도 매출 전망을 2억 3,500만~2억 7,500만 달러에서 3억 8,500만~4억 1,500만 달러로 상향 조정 (추정치 3억 8,028만 5천 달러) 노바백스, 2026회계연도 매출 전망을 2억 3,500만~2억 7,500만 달러에서 3억 8,500만~4억 1,500만 달러로 상향 조정 (추정치 3억 8,028만 5천 달러) Benzinga 2026.11.05 13:01 (GMT+0) Open on Benzinga Other news Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66 Nvidia’s China Exit Could Trigger a Bull-Bear Showdown: 6 Leveraged ETFs to Watch Wednesday OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform Quanterix Affirms FY2026 Sales Guidance of $142.000M-$146.000M vs $143.357M Est
OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform